Life Sciences Litigation: Senior Team

Life Sciences Litigation: Senior Team

Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357
Dr. Bell frequently testifies as an expert witness on damages in intellectual property, finance, and antitrust litigation in courts and arbitration proceedings in North America, Europe, Asia, and Australia. Dr. Bell’s business consulting engagements focus on the economics of business strategy, working with firms to develop sustainable competitive... Read more
Vice President
Washington, DC
+1-202-662-3935
Dr. Peter J. Rankin, Vice President, has been a member of CRA’s Life Sciences Practice since 1999, specializing in economic and strategic evaluation. His pharmaceutical research includes assessment of patent extension antitrust claims, class certification analysis, monetary damages from commercial and intellectual property disputes, international... Read more
Vice President
Toronto
+1-416-413-4084
Andrew Tepperman is a vice president in CRA’s Life Sciences Practice. Dr. Tepperman has considerable experience conducting economic analyses in intellectual property and antitrust litigation matters as well as in the context of other commercial disputes. His work has encompassed a variety of industries, including pharmaceuticals, biologics,... Read more
Principal
Washington, DC
+1-202-662-3926
Dr. Justin Ho is a principal in the Life Sciences Practice at CRA. He specializes in industrial organization and the economic and strategic evaluation of firm behavior and contracting. Dr. Ho’s research includes the welfare and competitive effects of introducing new contracts between players in the video rental market and the optimal design of... Read more
Principal
Washington, DC
+1-202-662-3861
Archan Ruparel is a principal in the Life Sciences Practice at CRA. His experience includes a variety of life sciences, healthcare, general antitrust, and commercial strategy work. Mr. Ruparel has worked on reverse payment litigation, antitrust investigations and litigation, and merger clearance before the Federal Trade Commission (FTC) and... Read more